| Wissenschaftl. Titel | A randomized, phase IIIB, open-label, two-arm, multicenter, comparatiVe study on efficacy and safety of lipegfilgrastim (Lonquex, TEVA) in comparison to pegfilgrastim (Neulasta, Amgen) in elderly patients with aggressive B cell Non-HOdgkin lymphomas at hIgh risk for R-CHOP-21-inDuced neutropenia – AVOID Neutropenia |
| Erkrankung |
Blut:
Non-Hodgkin-Lymphome (NHL), hoch-maligne:
Neu diagnostiziert / de novo
|
| weitere Prüfzentren | |
| Kurzprotokoll | Kurzprotokoll |
erstellt 06.07.2015 Hanna Ebert
geändert 16.08.2022 Student Studienregister